131 related articles for article (PubMed ID: 38463028)
21. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
22. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
[TBL] [Abstract][Full Text] [Related]
23. Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
Chen Q; Zhang L; Wan C; Yang B; Kong X; Xu X; Gu Y; Wang C; Liu X; Ding Q; Zhu L; Li Y; Wang B; Zhong W
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37203411
[TBL] [Abstract][Full Text] [Related]
24. Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma.
Xiao X; Jiang L; Hu H; Huang Y; Yang L; Jiao Y; Wei G
Mol Carcinog; 2021 Mar; 60(3):179-187. PubMed ID: 33434300
[TBL] [Abstract][Full Text] [Related]
25. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
[TBL] [Abstract][Full Text] [Related]
26. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
27. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
[TBL] [Abstract][Full Text] [Related]
28. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
29. PAI-1 overexpression promotes invasion and migration of esophageal squamous carcinoma cells.
Wang D; Yang LY; Liu Z; Yu J; Zhang MJ; Zhang Y; Cai Y; Xu X; Hao JJ; Wang MR
Yi Chuan; 2020 Mar; 42(3):287-295. PubMed ID: 32217514
[TBL] [Abstract][Full Text] [Related]
30. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
Zhang J; Kong R; Sun L
Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755
[TBL] [Abstract][Full Text] [Related]
31. LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
Zhang H; Pan E; Zhang Y; Zhao C; Liu Q; Pu Y; Yin L
BMC Cancer; 2022 Sep; 22(1):1017. PubMed ID: 36162992
[TBL] [Abstract][Full Text] [Related]
32. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
Zhang H; Han Y; Xiao W; Gao Y; Sui Z; Ren P; Meng F; Tang P; Yu Z
Cell Death Dis; 2023 Nov; 14(11):730. PubMed ID: 37949874
[TBL] [Abstract][Full Text] [Related]
33. [SERPINE2 promotes cellular migration and invasion in esophageal squamous cell carcinoma by activating β-catenin].
Zhang JL; Luo AP; Huang FR; Gong TY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):638-645. PubMed ID: 34289555
[No Abstract] [Full Text] [Related]
34. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
35. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
36. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma].
Zhao N; Gong TY; Wei ZC; Cong J; Liu ZH; Chen HY
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):99-107. PubMed ID: 38418183
[No Abstract] [Full Text] [Related]
37. A novel protein encoded by circUBE4B promotes progression of esophageal squamous cell carcinoma by augmenting MAPK/ERK signaling.
Lyu Y; Tan B; Li L; Liang R; Lei K; Wang K; Wu D; Lin H; Wang M
Cell Death Dis; 2023 Jun; 14(6):346. PubMed ID: 37264022
[TBL] [Abstract][Full Text] [Related]
38. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
[TBL] [Abstract][Full Text] [Related]
39. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
[TBL] [Abstract][Full Text] [Related]
40. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
